Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Diseases of the Esophagus

Chemotherapy Combined With Immunotherapy Followed by Salvage Lymphadenectomy for Recurrence in Cervical Lymph Nodes After Esophagectomy: A Single-Center Prospective Study

View Full Paper
Ask AI
Bookmark
Share

Authors

GZGuoqing ZhangTMTeng MuJWJunya Wang

Discussion

Loading...

Member takes

Overview

Single-center prospective study evaluates safety and effectiveness of salvage lymphadenectomy after immunotherapy in esophageal SCC recurrences.

Key Points

  • Salvage lymphadenectomy achieves R0 resection in 88.2% of patients treated with chemoimmunotherapy.
  • Grade III or higher adverse events occurred in 27.8% of patients, indicating significant risks involved.
  • The study assessed the impact of immunotherapy and chemotherapy on cervical node recurrences following esophagectomy.
  • Median recurrence-free survival and overall survival were recorded at 16.3 and 20.1 months, respectively.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/68c23cf6b210217d6478b7dehttps://doi.org/10.1093/dote/doaf061.275
View Full Paper
Ask AI
Bookmark
Share